DUAL-TARGET ANTIBODY TARGETING VEGFR-2 AND DLL4, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the ho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LEE, Hyuk Joon, SHIM, Sang Ryeol, YOO, Jin Sang, NAHM, Kyung Hee, KIM, Yeun Ju, PARK, In Sook, YOON, Jae Bong, YOO, Jin San, LEE, Weon Sup, KIM, Nam Ye, LEE, Eun Jin, LEE, Sang Hoon, KIM, Do Yun, LEE, Young Ae, NAM, Ju Ryung, OH, Seon Hwan, JEONG, Jong Geun, CHOI, Jin Hee, KIM, Joong Kyu, BYUN, Sang Soon, LEE, Jin Sook, JEONG, Bo Young, KIM, Sung Woo, PARK, Mi Ju, LEE, Seon Young
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.